Fact.MR – A Market Research and Competitive Intelligence Provider: The global Huntington’s disease treatment market was expected to attain market value of US$ 360 Mn in 2021.
North American Market is Expected to Account for 77% of Global Revenue for Huntington’s Disease Treatments
In a recent market study, Fact.MR covers recent developments in the global huntington’s disease treatment market, highlighting vital aspects such as trends, drivers, opportunities, and restraints. The report studies recent developments in the segments of the market in terms of treatment.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global Huntington’s disease treatment market was expected to attain market value of US$ 360 Mn in 2021. Relatively 31,000 people were affected by Huntington’s disease in North America, with a pervasiveness of 5.8 per 100,000 people.
The present market value of Huntington’s disease (HD) Treatment Market is US$ 432 Mn and by 2032, the market size will be CAGR of 20% and the Huntington’s disease treatment market value estimated to grow US$ 2.7 Bn
Ingrezza’s expected label extension to add chorea matched with Huntington’s disease, together with Huntington’s disease in western countries, is predicted be the market drivers. The children affected by Huntingtons’s disease is much lower, with around 5.1% to 10% of all cases.
For Critical Insights On This Market, Request For More Info
https://www.factmr.com/connectus/sample?flag=S&rep_id=7121
The global market for Huntington’s disease treatment is expected to grow the compound annual growth rate of 15.6% by 2021. North-America was the dominant regional market and has the highest market share.
The global huntington’s disease treatment market has seen a moderate growth rate of 7% from 2019. During the COVID-19 pandemic, online pharmacies sold off-label drugs to manage similar symptoms match with HD, such as antipsychotics, antidepressants, and anticonvulsants.
| Attributes | Details |
| Estimated value of the Huntington’s Disease Treatment Market in 2021 | US$ 360 Mn |
| Projected value of the Huntington’s Disease Treatment Market in 2022 | US$ 432 Mn |
| Projected value of the Huntington’s Disease Treatment Market in 2032 | US$ 2.7 Bn |
Key Takeaways:
- Huntington’s disease treatment market value is estimated to grow around US$ 432 Mn by 2022
- Asia Pacific will be attaining higher growth of 45% as Huntington’s disease treatment market share.
- Symptomatic Huntington’s disease treatment will be the most profitable accounting for 98% revenue
- North America is to attain 77% of the global market for the treatment of Huntington’s disease
- Disease modifying therapies allocated US$ 4.2 Bn by 2021 and estimated to grow at a 9.1% CAGR until 2032
Growth Drivers:
- The involvement of major market players is expected to provide higher market growth for a cure for Huntington’s disease (HD). Patient population is been growing high in numbers and pervasiveness of diseases across world, mainly in North America and Europe.
- The disease-modifying therapies segment is estimated to grow at the fastest rate by 2032. An increasing demand for advanced products, such as gene therapy and stem cell therapy are responsible for the Huntington’s disease treatment market growth.
To learn more about Huntington’s disease treatment market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7121
Competitive Landscape:
Several key players are fostering different strategies to attain larger market share, including new product development and partnerships.
- Spark Therapeutics, Inc. (a subsidiary of F. Hoffmann La Roche Ltd.) formed a partnership with NeuExcell Therapeutics Inc to develop gene therapy for treating HD patients.
- Austedo, a drug expected to treat chorea associated with HD by Teva Pharmaceutical Industries Ltd, has been approved by the National Medical Products Association (NMPA) in China. The company is to expand its patient base and revenue by geographical expansion.
- Prilenia Therapeutics B.V. announced its participation in the H.C. Walkewright 23rd Annual Global Investment Conference, Cantor Virtual Global Healthcare Conference, and European Huntington Disease Network to present phase 3 results for candidate pridopidine.
Key Players in the Huntington’s Disease Treatment Market Include:
- H. Lundbeck A/S
- Bausch Health Companies Inc.
- Hetero Drugs
- Lupin Limited
- Hikma Pharmaceuticals Plc.
- Dr. Roddy’s Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
More Valuable Insights on Huntington’s Disease Treatment Market
Fact.MR provides an unbiased analysis of the Huntington’s disease treatment market, presenting forecast statistics for the period from 2022-2032. The study divulges compelling insights on the global Huntington’s disease treatment market with a detailed segmentation on the basis of:
- By Treatment
- Symptomatic Treatment of Huntington’s disease
- Disease-Modifying Therapies for Huntington’s disease
Key Questions Covered in Huntington’s Disease Treatment Market Report
- What was the market worth for Huntington’s disease treatment in 2021?
- What is the expected market worth for Huntington’s disease treatment in 2022?
- At what CAGR did the market for Huntington’s disease treatment surge from 2015 to 2021?
- At what rate will the market for Huntington’s disease treatment expand until 2032?
- What is the expected market value for Huntington’s disease treatment in 2032?
- What is the growth outlook for Huntington’s disease treatment across North America?
- How opportunistic will the industry likely be across the Asia-Pacific?
- Which treatment category is expected to be dominant for Huntington’s disease?
Explore Fact.MR’s Coverage on the Healthcare Domain –
Genetic Testing Services Market Analysis - Genetic testing services are now widely used for a variety of applications in oncology, obstetrics, and ancestry. These services are intended to assist clinicians and patients in identifying hereditary factors that contribute to the outbreak of the aforementioned diseases.
DNA Probes based Diagnostics Market Trends - The public’s awareness of this technology for prenatal diagnosis and carrier detection is fast rising, and demand for such services is projected to skyrocket in the coming years. Furthermore, the worldwide DNA probes based diagnostics market is expected to benefit from increased automation in diagnosis testing.
Genitourinary Cancers Treatment Market Forecast - The geriatric population is growing, with more people suffering from the risk factors for genitourinary cancer. The market for genitourinary cancer treatment is being driven by an increase in the incidence of genitourinary cancers.
Polycystic Kidney Disease Treatment Market Scope – Rising prevalence of ADPKD globally, increasing incidences of kidney failure, and favorable reimbursements in developed countries are the major factors expected to drive the growth of the polycystic kidney disease treatment market.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR